5 insiders bought €574k of shares over the last 90 days, the latest filed 29 Sept 2026.
Cluster: 4 buyers in 30 daysAsker Healthcare Group AB (publ), classified in the Health Care sector, is a listed company. Its insiders report their share dealings to Finansinspektionen. From 18 October 2025 to 18 October 2026, the disclosure feed for Asker Healthcare Group AB (publ) logged 23 filings by 12 insiders.
Open-market activity splits into 14 purchases totalling €1.3M and 8 sales totalling €16.3M; 9 insiders sit on the buying side and 6 insiders on the selling side. Netting one side against the other leaves €15.0M of net selling. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Those buying include 5 board members, 1 senior executive and 1 chief executive. At €7.2M, the sale published on 29 May 2026 by Johan Falk is the largest of the period (0.27% of market cap).
With 23 filings in twelve months, the company is more active than the median of 7 filings across the 886 companies we follow on the same exchange. Our records for Asker Healthcare Group AB (publ) go back to 2025, with 14 purchases and 23 sales on the open market in total.
In all, 12 purchases were made within 30 days of a purchase by another insider of the company. Purchases made close together by different insiders form what is called a cluster. The clock since the last published purchase (29 September 2026) now reads 18 days. Typically, a trade is published a median of 1 day after it takes place. Under the Market Abuse Regulation, managers have three business days to notify their trades.
For comparison within the same sector, see the insider buying recorded at MAIA Biotechnology, Inc. and Cooper Companies, Inc. Source: insider filings from Finansinspektionen. Past trades are no guide to future returns.
+11 other insiders
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Analysts rate Asker Healthcare Group AB (publ) Buy (bullish), based on 5 analysts. Average price target: SEK 89.90.
Transparent value + quality ranking, distinct from the insider signal.
FY ended December 2025 · cache
25 of 52 declarations
Asker Healthcare Group AB (publ) is a publicly traded company on the XSTO market, specializing in the healthcare and pharmaceutical sector. It focuses on developing and marketing innovative solutions to enhance healthcare.
Asker Healthcare drew five insider buyers in late September as the stock sat near SEK 60-64, after a solid Q2 and a year...
Asker’s September buy cluster lands after a sharp 2026 slide. Here is how the distributor makes money, what the filings ...
Two Asker board members bought EUR 216k of stock on September 25, after a CEO buy and while the acquirer keeps hitting m...
Asker Healthcare drew a 5-insider buy cluster in September. Here is how the filings fit a pressured medtech tape, and wh...